Blueclinical Phase I's mission is to conduct effective studies in healthy subjects and early stage studies in patients, in full compliance with the international regulations.

Studies in healthy subjects are conducted in Blueclinical's own phase I unit located at Hospital da Prelada, Porto. The clinical and scientific team has experience in diverse types of studies for the global market, both with generics (bioavailability / bioequivalence) and innovative medicines.